Status: current, Defined. Date: 31-Dec 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4650761000168119 | Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride 160 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL) gel, 5 x 4 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4650771000168113 | Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | Is a | adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine hydrochloride 4% gel, 5 x 4 mL vials | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | has TP | Laceraine Topical Wound Anaesthetic | true | Inferred relationship | Some | ||
| Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | has TPUU | Laceraine Topical Wound Anaesthetic gel, 4 mL vial | true | Inferred relationship | Some | 652891371 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | Is a | True | Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product pack reference set
FHIR